Assessment of Cardiovascular Risk by the Combination of Clinical Risk Scores Plus Platelet Expression of FcγRIIa

Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention

Robert W. Yeh, Eric A. Secemsky, Sharon‐Lise T. Normand et al. · JAMA · 2016 · 911 citations · Full text

Medicine, Cardiology, Pharmacotherapy +16

Identification of FcγRIIa as the ITAM-bearing receptor mediating αIIbβ3 outside-in integrin signaling in human platelets

Brian Boylan, Cunji Gao, Vipul Rathore et al. · Blood · 2008 · 181 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +16

Late Consequences of Acute Coronary Syndromes: Global Registry of Acute Coronary Events (GRACE) Follow-up

Sami Alnasser, Wei Huang, Joel M. Gore et al. · The American Journal of Medicine · 2014 · 111 citations

Medicine, Cardiology, Internal Medicine +16

Variability of Individual Platelet Reactivity Over Time in Patients Treated With Clopidogrel

Willibald Hochholzer, Christian T. Ruff, R. A. Mesa et al. · Journal of the American College of Cardiology · 2014 · 80 citations · Full text

Medicine, Hematology, Pharmacology +14

External Validation of the DAPT Score in a Nationwide Population

Peter Ueda, Tomas Jernberg, Stefan James et al. · Journal of the American College of Cardiology · 2018 · 71 citations

Pharmacy, Biostatistics, Method Validation +6